Collin Michael Reiff MD
Addiction, Psychopharmacology, Integrative Psychiatry
Clinical Assistant Professor of Psychiatry NYU Grossman School of Medicine
Join to View Full Profile
303 5th AveSuite: 608New York, NY 10016
Dr. Reiff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Collin Reiff is a psychiatrist in New York, NY and is affiliated with NYU School of Medicine, and NYU Langone Medical Center. He specializes in treating Addiction, Post Traumatic Stress Disorder, Mood and Anxiety Disorders, ADHD, Bipolar Disorder and psychotic spectrum disorders. He uses psychotherapy and medication to improve the lives of his patients.
Education & Training
NYU Grossman School of MedicineFellowship, Addiction Psychiatry, 2018 - 2019
Emory University School of MedicineChief Residency, Psychiatry, 2017 - 2018- Emory University School of MedicineResidency, Psychiatry, 2014 - 2018
Tel Aviv University SacklerClass of 2014
Emory UniversityBA, Religious Studies, John Fenton Prize in Religion
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2018 - 2025
GA State Medical License 2017 - 2020
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- Rapid Effects of MDMA Administration on Self-Reported Personality Traits and Affect State: A Randomized, Placebo-Controlled Trial in Healthy Adults.Jessica L Maples-Keller, Courtland S Hyatt, Nathaniel L Phillips, Brinkley M Sharpe, Andrew Sherrill
Journal of Psychoactive Drugs. 2024-10-23 - Perceived Conjunctival Foreign Material Egress in Morgellons Disease: A Case Study.Sean Ghiam, Badal Sojitra, Collin Reiff, Connie M Sears, Justin N Karlin
Case Reports in Psychiatry. 2024-01-01 - 29 citationsA randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults.Jessica L Maples-Keller, Seth D Norrholm, Mark Burton, Collin Reiff, Callan Coghlan
Journal of Psychopharmacology. 2022-03-01
Press Mentions
The Rise of Psychedelic RetreatsNovember 25th, 2021- Psychedelic Drugs Could Help Treat Mental Health Problems. But Can You Get There Without the Trip?May 13th, 2021
- ‘A Hail Mary’: Psychedelic Therapy Draws Veterans to Jungle RetreatsAugust 30th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
